Since its inception in 1901, Children’s Hospital Los Angeles (CHLA) has become one of the nation’s leading academic hospitals dedicated to treating children with medically complex diseases and injuries. Operating around its mission of creating hope and building healthier futures, CHLA provides world-class clinical care, performs leading-edge research, and offers one of the most successful pediatric training programs in the country. As the only pediatric safety net hospital in the region, it has staff and faculty across 350 pediatric specialty programs and services and is able treat a wide range or rare and common diseases. With 70 percent of its inpatient population relying on Medi-Cal, it treats the most vulnerable patients in Los Angeles County and surrounding communities. In the previous year, CHLA treated more than 121,000 patients in over 620,000 patient visits. Of these patients, approximately 3,000 were from Ventura County.
CHLA’s Cancer and Blood Disease Institute (CBDI) has been saving lives and working to improve cure rates through exceptional care, innovative research, and academic excellence for nearly six decades. Last year, the CBDI treated 6,000 unique patients and completed approximately 33,500 outpatient visits. Further, it conducted extensive research across 157 clinical trials and 808 clinical trials enrollments. Recently, the U.S. News & World Report ranked the CBDI as the top pediatric hematology/oncology program in California and the western United States and No. 5 in the nation. The Institute has been continuously ranked in the top ten every year since these rankings were launched in 2008.